D. E. Shaw & Co., Inc. - ENZON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$15,000
-63.4%
14,073
-64.2%
0.00%
Q2 2014$41,000
+2.5%
39,3110.0%0.00%
Q1 2014$40,000
-13.0%
39,3110.0%0.00%
Q4 2013$46,000
-64.3%
39,311
-48.9%
0.00%
Q3 2013$129,000
-39.4%
76,860
-27.8%
0.00%
Q2 2013$213,000106,4560.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baupost Group 4,337,858$5,032,0000.14%
PRICE MICHAEL F 748,200$868,0000.11%
ALGERT GLOBAL LLC 124,891$145,0000.04%
Rotella Capital Management, Inc. 13,701$16,0000.03%
Icahn Capital 5,904,863$6,850,0000.02%
Spark Investment Management LLC 110,100$127,0000.02%
FCG ADVISORS, LLC 20,000$23,0000.02%
BRANDES INVESTMENT PARTNERS, LP 1,023,893$1,188,0000.02%
GLOBEFLEX CAPITAL L P 101,454$117,0000.01%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 129,089$149,0000.01%
View complete list of ENZON PHARMACEUTICALS INC shareholders